Degenerative Disorder Clinical Trials

10 recruitingLast updated: June 18, 2026

There are 10 actively recruiting degenerative disorder clinical trials across 10 countries. Studies span Not Applicable, Phase 1, Phase 2. Top locations include St Louis, Missouri, United States, San Francisco, California, United States, Bloomington, Indiana, United States. Updated daily from ClinicalTrials.gov.


Degenerative Disorder Trials at a Glance

10 actively recruiting trials for degenerative disorder are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in St Louis, San Francisco, and Bloomington. Lead sponsors running degenerative disorder studies include Hadassah Medical Organization, Medtronic Spinal and Biologics, and Fujian Medical University Union Hospital.

Browse degenerative disorder trials by phase

Treatments under study

About Degenerative Disorder Clinical Trials

Looking for clinical trials for Degenerative Disorder? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Degenerative Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Degenerative Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Not Applicable

The Ailliance Post-Market Clinical Study

Spinal DeformitySpinal Degenerative DisorderSpinal Fusion Failure+2 more
Medtronic Spinal and Biologics1,000 enrolled27 locationsNCT05856370
Recruiting

Construction of AI Model for Precision Imaging Diagnosis of Cranial Diseases

Cranial Diseases (e.g., Brain Tumors, Stroke, Neurodegenerative Disorders)
Tongji Hospital1,000 enrolled1 locationNCT07446842
Recruiting
Not Applicable

Elemental 028 Extra Case Studies

MalabsorptionAllergiesGastrointestinal Disease+3 more
Nutricia UK Ltd30 enrolled1 locationNCT06877923
Recruiting
Not Applicable

Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance

Insulin ResistanceCognitive DeclineMild Cognitive Impairment+1 more
SF Research Institute, Inc.140 enrolled1 locationNCT07220694
Recruiting

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

Movement DisordersAmyotrophic Lateral SclerosisDegenerative Disorder+1 more
Target ALS Foundation, Inc.1,000 enrolled12 locationsNCT05137665
Recruiting

Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases

Neurodegenerative Disorders
Hadassah Medical Organization120 enrolled1 locationNCT00874783
Recruiting

A Registered Cohort Study on Neurodegenerative Associated With Sleep Disorder.

Neurodegenerative disorder
Fujian Medical University Union Hospital500 enrolled1 locationNCT05524922
Recruiting

Characterising and Tracking of Patients with Inherited Neurodegenerative Disorders (INDD)

Inherited Neurodegenerative Disorders
St Vincent's Health Network100 enrolled1 locationACTRN12624000381583
Recruiting
Phase 1Phase 2

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Sexual DysfunctionAutoimmune DiseasesNeurologic Disorders+8 more
Thomas Advanced Medical LLC5,000 enrolled1 locationNCT04684602
Recruiting

A Randomised Control Trial for Advance Care Planning and Symptom Management for patients identified in the emergency department and followed up at home

Advanced progressive life-threatening illnesseslife-threatening malignancyprogressive neuro-degenerative disorders+3 more
Prince of Wales Hospital500 enrolled1 locationACTRN12614000590662